Philips joins Irish Aerogen for nebulizer license; Oramed snags Australia, Israel patents for oral insulin;

> Philips ($PHG) signed a deal with Galway, Ireland-based devicemaker Aerogen to license Aerogen's homecare nebulizer technology. More

> Oramed ($ORMP) secured a patent in Australia and its home country of Israel for a core concept of its insulin oral delivery. This adds to a list of countries that have allowed the patent, including Japan, China, Russia and New Zealand. Release

> Researchers at Emory University have created a luteolin-delivering nanoparticle that could aid in cancer prevention. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.